|
US3891427A
(en)
*
|
1972-10-12 |
1975-06-24 |
Lectromelt Corp |
Method for melting prereduced ore and scrap
|
|
SE378735B
(de)
*
|
1972-11-17 |
1975-09-08 |
Asea Ab |
|
|
FR2220584B1
(de)
*
|
1973-03-05 |
1976-05-21 |
Siderurgie Fse Inst Rech |
|
|
US3939297A
(en)
*
|
1973-12-07 |
1976-02-17 |
Chase Brass & Copper Co., Incorporated |
Stoker feed system
|
|
SE7503782L
(sv)
*
|
1975-04-02 |
1976-10-03 |
Asea Ab |
Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
|
|
US4133967A
(en)
*
|
1977-06-24 |
1979-01-09 |
The United States Of America As Represented By The Secretary Of The Interior |
Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
|
|
US4447906A
(en)
*
|
1981-02-02 |
1984-05-08 |
Lectromelt Corporation |
Arc furnace for producing aluminum
|
|
SE8303372L
(sv)
*
|
1983-06-14 |
1984-12-15 |
Asea Ab |
Ugnsanordning for smeltning av metaller eller metallegeringar
|
|
AT384669B
(de)
*
|
1986-03-17 |
1987-12-28 |
Voest Alpine Ag |
Anlage zur herstellung von stahl aus schrott
|
|
CA1311787C
(en)
*
|
1986-06-24 |
1992-12-22 |
Masahisa Tate |
Method of bottom blowing operation of a steel making electric furnace
|
|
FR2705767B1
(fr)
*
|
1993-05-27 |
1995-07-21 |
Lorraine Laminage |
Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
|
|
DE4339226A1
(de)
*
|
1993-11-15 |
1995-05-18 |
Mannesmann Ag |
Verfahren und Vorrichtung zur Wertstoffgewinnung
|
|
AT404841B
(de)
|
1995-04-10 |
1999-03-25 |
Voest Alpine Ind Anlagen |
Anlage und verfahren zum herstellen von eisenschmelzen
|
|
US6673827B1
(en)
|
1999-06-29 |
2004-01-06 |
The Uab Research Foundation |
Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
|
|
US7227011B2
(en)
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
|
DE60021724D1
(de)
*
|
1999-05-18 |
2005-09-08 |
Danieli Technology Inc |
Elektrischer lichtbogenofen und verfahren zum kontinuierlichen chargieren
|
|
EP1702983A3
(de)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Gewebespezifische und pathogenspezifische giftige Verbindungen, Ribozyme, DNAzyme und Antisenseolinukleotide sowie Anwendungen dafür
|
|
US20040067991A1
(en)
*
|
2000-07-06 |
2004-04-08 |
Greig Nigel H |
Tetrahydrobenzothiazole analogues as neuroprotective agents
|
|
AU2001276957A1
(en)
*
|
2000-07-17 |
2002-01-30 |
Advanced Research And Technology Institute |
Method of diagnosing pulmonary hypertension
|
|
EP2336166A1
(de)
|
2000-10-12 |
2011-06-22 |
University Of Rochester |
Zusammensetzungen die die Proliferation von Krebszellen hemmen
|
|
AU2002303277A1
(en)
*
|
2001-04-06 |
2002-10-21 |
Vladimir Larionov |
Artificial chromosomes that can shuttle between bacteria, yeast, and mammalian cells
|
|
EP1439849A4
(de)
*
|
2001-10-01 |
2005-09-28 |
Univ Vanderbilt |
Verwendung von calmodulin-kinase-ii-hemmern zur behandlung von myokardialer funktionsstörung bei struktureller herzkrankheit
|
|
US20040248289A1
(en)
*
|
2001-10-04 |
2004-12-09 |
Vladimir Noskov |
Tandem repeat markers
|
|
MXPA04007586A
(es)
|
2002-02-06 |
2005-06-08 |
Vicor Technologies Inc |
Moleculas anti-infarto.
|
|
WO2004001655A1
(en)
|
2002-06-14 |
2003-12-31 |
The Govermment Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Office Of Technology Transfer |
Methods of treating and preventing colitis involving il-13 and nk-t cells
|
|
CA2495478A1
(en)
|
2002-08-05 |
2004-02-12 |
University Of Rochester |
Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
|
|
CN100594037C
(zh)
|
2002-11-15 |
2010-03-17 |
Musc研究发展基金会 |
通过补体受体2定向的补体调节剂
|
|
AU2003294462C1
(en)
|
2002-11-21 |
2011-06-30 |
University Of Utah Research Foundation |
Purinergic modulation of smell
|
|
CA2553745A1
(en)
|
2004-01-21 |
2005-08-04 |
University Of Utah Research Foundation |
Mutant sodium channel nav1.7 and methods related thereto
|
|
CA2558025A1
(en)
|
2004-03-04 |
2005-09-22 |
Vanderbilt University |
Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling
|
|
EP1734821A4
(de)
*
|
2004-04-14 |
2011-07-06 |
Uab Research Foundation |
Aktivatoren der hexosaminbiosynthese als hemmer für durch ischämieschock oder hämorrhagischen schock induzierte schäden
|
|
US20050244335A1
(en)
*
|
2004-05-03 |
2005-11-03 |
Rinehart John J |
Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
|
|
US20080269116A1
(en)
|
2004-05-11 |
2008-10-30 |
Taub Dennis D |
Methods of Inhibiting Proinflammatory Cytokine Expression Using Ghrelin
|
|
CA2564251C
(en)
|
2004-05-21 |
2018-04-10 |
The Uab Research Foundation |
Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
|
|
AU2005306403A1
(en)
*
|
2004-11-18 |
2006-05-26 |
University Of Rochester |
Methods and compositions related to Esculentoside A
|
|
AU2005319155B2
(en)
|
2004-12-21 |
2013-01-31 |
Musc Foundation For Research Development |
Compositions and methods for promoting wound healing and tissue regeneration
|
|
WO2008157840A2
(en)
|
2007-06-21 |
2008-12-24 |
Musc Foundation For Research Development |
Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration
|
|
US9072716B2
(en)
|
2005-04-15 |
2015-07-07 |
The United States of America, as represented by the Secretary Department of Health by Human Servies |
Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells
|
|
WO2006127020A1
(en)
|
2005-05-19 |
2006-11-30 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention |
FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF
|
|
US8859585B2
(en)
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
JP5886511B2
(ja)
|
2005-06-07 |
2016-03-16 |
ディーエスエム ニュートリショナル プロダクツ アーゲーＤＳＭ Ｎｕｔｒｉｔｉｏｎａｌ Ｐｒｏｄｕｃｔｓ ＡＧ |
脂質および抗酸化剤の製造のための真核微生物
|
|
EP2392646A1
(de)
|
2005-10-14 |
2011-12-07 |
MUSC Foundation For Research Development |
Targeting von PAX2 zur Induktion der DEFB1-vermittelten Tumorimmunität und Krebstherapie
|
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
DK1976985T3
(da)
|
2005-12-29 |
2013-10-21 |
Univ California |
Fremgangsmåder og præparater relateret til mutant Kunitz-domæne I af TFPI-2
|
|
JP2009523129A
(ja)
|
2006-01-05 |
2009-06-18 |
ユニバーシティ オブ ユタ リサーチ ファウンデーション |
神経系を標的する薬理学的物質の性質を改善することに関連する方法および組成物
|
|
CA2638911C
(en)
|
2006-02-06 |
2018-01-23 |
Burnham Institute For Medical Research |
Methods and compositions related to targeting tumors and wounds
|
|
AU2007223427A1
(en)
*
|
2006-03-01 |
2007-09-13 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
US8470965B2
(en)
*
|
2006-03-01 |
2013-06-25 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
JP2009528545A
(ja)
|
2006-03-02 |
2009-08-06 |
ザ ユーエービー リサーチ ファウンデーション |
マイコバクテリウム属の疾患検出、処置、および薬物開発
|
|
US8524741B2
(en)
|
2006-07-10 |
2013-09-03 |
Synapsin Pharmaceuticals, Inc. |
Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing cognitive and physical performance
|
|
AU2007281284A1
(en)
|
2006-08-02 |
2008-02-07 |
The Uab Research Foundation |
Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
|
|
AU2007297535C1
(en)
|
2006-09-21 |
2017-11-23 |
University Of Florida Research Foundation, Inc. |
Compositions and methods related to protein displacement therapy for myotonic distrophy
|
|
WO2008136852A2
(en)
|
2006-11-01 |
2008-11-13 |
University Of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
|
CA2672297A1
(en)
|
2006-12-11 |
2008-06-19 |
University Of Utah Research Foundation |
Compositions and methods for treating pathologic angiogenesis and vascular permeability
|
|
WO2008089440A2
(en)
|
2007-01-18 |
2008-07-24 |
University Of Utah Research Foundation |
Compositions and methods for detecting, treating, or preventing reductive stress
|
|
CA2677665C
(en)
|
2007-02-08 |
2019-11-05 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
EP2139319A4
(de)
|
2007-03-22 |
2011-02-23 |
Univ Yale |
Verfahren und zusammensetzungen für riboswitches, die das alternative spleissen kontrollieren
|
|
WO2009017863A2
(en)
|
2007-05-08 |
2009-02-05 |
Burnham Institute For Medical Research |
Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
|
|
EP2155894A4
(de)
|
2007-05-09 |
2010-08-18 |
Burnham Inst Medical Research |
Wirtsproteinasen als ziel für eine therapeutische strategie gegen virale und bakterielle krankheitserreger
|
|
US8329195B2
(en)
|
2007-05-23 |
2012-12-11 |
The Uab Research Foundation |
Detoxified pneumococcal neuraminidase and uses thereof
|
|
CN101849020A
(zh)
|
2007-05-29 |
2010-09-29 |
耶鲁大学 |
核糖开关及使用核糖开关的方法和组合物
|
|
WO2009021163A2
(en)
*
|
2007-08-08 |
2009-02-12 |
University Of Rochester |
Enhancing gene transfer
|
|
TW200916113A
(en)
|
2007-08-08 |
2009-04-16 |
Sod Conseils Rech Applic |
Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
|
|
WO2009042294A2
(en)
*
|
2007-08-10 |
2009-04-02 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
EP2268664B1
(de)
|
2007-12-03 |
2017-05-24 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Doc1-zusammensetzungen und verfahren zur behandlung von krebs
|
|
US20090233993A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
|
US20110262395A1
(en)
|
2008-05-08 |
2011-10-27 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
US8816095B2
(en)
*
|
2008-08-15 |
2014-08-26 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
WO2010065617A1
(en)
|
2008-12-02 |
2010-06-10 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
US20100286762A1
(en)
*
|
2009-03-18 |
2010-11-11 |
Musc Foundation For Research Development |
Compositions and Methods for Ameliorating Clinical Electrical Disturbances
|
|
US20120107331A1
(en)
|
2009-05-15 |
2012-05-03 |
Yale University |
Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
WO2011022502A1
(en)
|
2009-08-18 |
2011-02-24 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
US20110060000A1
(en)
|
2009-09-10 |
2011-03-10 |
Maurizio Grimaldi |
Acridine analogs in the treatment of gliomas
|
|
US20120321647A1
(en)
|
2010-01-12 |
2012-12-20 |
Yale University |
Structured rna motifs and compounds and methods for their use
|
|
EP2544715A2
(de)
|
2010-03-09 |
2013-01-16 |
Board Of Regents, University Of Texas System |
Verfahren und zusammensetzung für chlamydia-antigen zur diagnose und behandlung einer chlamydieninfektion und -erkranung
|
|
WO2011127405A1
(en)
|
2010-04-08 |
2011-10-13 |
Sanford-Burnham Medical Research Institute |
Methods and compositions for enhanced delivery of compounds
|
|
US20130143955A1
(en)
|
2010-08-09 |
2013-06-06 |
Yale University |
Cyclic di-GMP-II Riboswitches, Motifs, and Compounds, and Methods for Their Use
|
|
CN103517712A
(zh)
|
2010-12-15 |
2014-01-15 |
神经佐剂股份有限公司 |
神经肽类似物、组合物和治疗疼痛的方法
|
|
RU2013145892A
(ru)
|
2011-03-15 |
2015-04-20 |
Юниверсити Оф Юта Рисерч Фаундейшн |
Способы диагностики и лечения сосудисто-ассоциированной макулопатии и ее симптомов
|
|
JP6205345B2
(ja)
|
2011-03-28 |
2017-09-27 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
ウイルス侵入の阻害に関する方法および組成物
|
|
US10766937B2
(en)
|
2011-09-06 |
2020-09-08 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods of treating cancer
|
|
EP3608401A1
(de)
|
2012-07-05 |
2020-02-12 |
Ohio State Innovation Foundation |
Zusammensetzungen und verfahren in zusammenhang mit viralen impfstoffen
|
|
WO2014141111A1
(en)
|
2013-03-14 |
2014-09-18 |
Pluristem Ltd. |
Methods for prevention and treatment of graft-versus-host disease
|
|
US9783576B2
(en)
|
2013-06-11 |
2017-10-10 |
Sanford-Burnham Medical Research Institute |
Compositions and methods for targeted endometriosis treatment
|
|
AU2014285079A1
(en)
|
2013-07-05 |
2016-01-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Soluble CD33 for treating myelodysplastic syndromes (MDS)
|
|
WO2015143335A1
(en)
|
2014-03-20 |
2015-09-24 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric coronavirus spike proteins
|
|
WO2016049380A1
(en)
|
2014-09-24 |
2016-03-31 |
University Of Utah Research Foundation |
Ebolavirus pre-hairpin intermediate mimics and methods of use
|
|
JP2018504141A
(ja)
|
2015-01-20 |
2018-02-15 |
アドキュア バイオテクノロジーズ、 エルエルシー |
非標的化アデノウイルス変異体および関連する方法
|
|
US10596247B2
(en)
|
2015-02-20 |
2020-03-24 |
Board Of Regents, The University Of Texas System |
Methods and compositions for attenuated chlamydia as vaccine and vector
|
|
WO2017040350A1
(en)
|
2015-08-28 |
2017-03-09 |
Navigen, Inc |
Compositions and methods related to inhibition of respiratory syncytial virus entry
|
|
WO2017120549A1
(en)
|
2016-01-07 |
2017-07-13 |
Navigen, Inc. |
D-peptide inhibitors of hiv entry and methods of use
|
|
US10751340B2
(en)
|
2016-06-06 |
2020-08-25 |
University Of Central Florida Research Foundation, Inc. |
Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
|
|
SG11201900815UA
(en)
|
2016-07-29 |
2019-02-27 |
Ohio State Innovation Foundation |
Expression of pten-long with ocolytic viruses
|
|
KR20240042177A
(ko)
|
2016-10-05 |
2024-04-01 |
유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 |
Nk 세포 및 항-pdl1 암 요법과 관련된 방법 및 조성물
|
|
EP4215201A1
(de)
|
2017-03-24 |
2023-07-26 |
Ohio State Innovation Foundation |
Neuartige rekombinante adeno-assoziierte virale vektoren zur einschränkung der off-target-transduktion in der leber und verwendungen davon
|
|
JP7346302B2
(ja)
|
2017-03-28 |
2023-09-19 |
オハイオ・ステイト・イノベーション・ファウンデーション |
ヒトｐｄ－１ペプチドワクチン及びその使用法
|
|
US20230140818A1
(en)
|
2017-04-27 |
2023-05-04 |
The University Of Hong Kong |
Use of hcn inhibitors for treatment of cancer
|
|
WO2018218151A1
(en)
|
2017-05-25 |
2018-11-29 |
University Of Central Florida Research Foundation, Inc. |
Novel oncolytic viruses for sensitizing tumor cells to killing by natural killer cells
|
|
WO2019067403A2
(en)
|
2017-09-26 |
2019-04-04 |
Sanford Burnham Prebys Medical Discovery Institute |
COMPOSITIONS AND METHODS FOR EVALUATION OF PAINFUL DEMYELINIZING AND NON-DEMYELING DISEASES
|
|
JP2021506763A
(ja)
|
2017-12-13 |
2021-02-22 |
ノース カロライナ ステート ユニバーシティＮｏｒｔｈ Ｃａｒｏｌｉｎａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ |
化学療法剤とチェックポイント阻害剤とを含む組成物及び使用の方法
|
|
US20210023219A1
(en)
|
2018-04-06 |
2021-01-28 |
North Carolina State University |
Cell assembly-mediated delivery of checkpoint inhibitors for cancer immunotherapy
|
|
US11717551B2
(en)
|
2018-05-07 |
2023-08-08 |
Georgia State University Research Foundation, Inc. |
Compositions and methods related to Rhamnus prinoides (GESHO) extract for the inhibition of polymicrobial biofilm formation
|
|
EP3813884A4
(de)
|
2018-06-29 |
2022-03-23 |
North Carolina State University |
In situ gesprühtes bioresponsives immuntherapeutisches gel zur postoperativen behandlung
|
|
US20210317479A1
(en)
|
2018-09-06 |
2021-10-14 |
The Broad Institute, Inc. |
Nucleic acid assemblies for use in targeted delivery
|
|
US11331269B2
(en)
|
2018-09-06 |
2022-05-17 |
Massachusetts Institute Of Technology |
Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
|
|
US20210388389A1
(en)
|
2018-10-30 |
2021-12-16 |
Yale University |
Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
|
|
WO2020161686A1
(en)
|
2019-02-09 |
2020-08-13 |
King Abdullah University Of Science And Technology |
Compositions and methods for cancer diagnosis and prognosis
|
|
MX2021015970A
(es)
|
2019-06-21 |
2022-04-06 |
Vaccinex Inc |
Terapia de combinacion con bloqueo de semaforina-4d (sema4d) y terapia de dc1.
|
|
US11225508B1
(en)
|
2020-09-23 |
2022-01-18 |
The University Of North Carolina At Chapel Hill |
Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
|
|
EP4251283A1
(de)
|
2020-11-27 |
2023-10-04 |
General Nanotherapeutics LLC |
Verfahren und zusammensetzung zur behandlung von immunvermittelten erkrankungen
|
|
US20230279442A1
(en)
|
2021-12-15 |
2023-09-07 |
Versitech Limited |
Engineered cas9-nucleases and method of use thereof
|
|
WO2023173137A1
(en)
|
2022-03-11 |
2023-09-14 |
Yale University |
Compositions and methods for efficient and stable genetic modification of eukaryotic cells
|
|
WO2023220644A1
(en)
|
2022-05-10 |
2023-11-16 |
Yale University |
Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
|
|
KR20230167924A
(ko)
*
|
2022-06-03 |
2023-12-12 |
현대제철 주식회사 |
전기로
|
|
WO2024064824A2
(en)
|
2022-09-21 |
2024-03-28 |
Yale University |
Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
|
|
US20240158490A1
(en)
|
2022-11-11 |
2024-05-16 |
Jeff R. Peterson |
Gout flare prevention methods using il-1beta blockers
|
|
WO2024155821A1
(en)
|
2023-01-18 |
2024-07-25 |
Yale University |
Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
|